Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

Clinical trial NCT05599919 · COMPLETED

Trial details

NCT number: NCT05599919
Sponsor: Sanotize Research and Development corp.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-11-01
Primary completion: 2022-01-31
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.